glutamine has been researched along with Cachexia in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (29.27) | 18.2507 |
| 2000's | 7 (17.07) | 29.6817 |
| 2010's | 16 (39.02) | 24.3611 |
| 2020's | 6 (14.63) | 2.80 |
| Authors | Studies |
|---|---|
| Higaki, Y; Kunitake, N; Kuroki, K; Masuda, M; Rikimaru, F; Toh, S | 1 |
| Fan, Q; Hanse, EA; Kong, M; Lowman, XH; Ruiz, BI; Wang, T; Wu, H; Yang, Y | 1 |
| Araújo Júnior, RF; Araújo, AA; Clebis, NK; Fracaro, L; Lacchini, S; Lima, KRA; Lima, MFO; Lins, LAA; Lopes, MLDS; Perles, JVCM; Purificação, NRCD; Souza, SRG; Zanoni, JN | 1 |
| Barbosa Bazotte, R; da Silva, FG; de Fatima Silva, F; de Morais, H; de Souza, HM; Ortiz Silva, M; Rafael Carpinelli, A; Rodrigues Graciano, MF; Serrano-Nascimento, C; Vianna Croffi, R | 1 |
| Al-Shayyab, S; Al-Shebli, H; Almanaseer, A; Alshawabkeh, A; Badwan, S; Fannoun, R; Obeidat, M; Younes, MNB | 1 |
| Billingham, L; Gaskell, C; Gaunt, C; Jackson, A; Pascoe, J; Steven, N; Thompson, J | 1 |
| Bazotte, RB; Bossolani, GD; Fávaro, LD; Fracaro, L; Frez, FC; Guarnier, FA; Hermes-Uliana, C; Lima, MM; Manzano, MI; Martins, HA; Vicentini, GE; Zanoni, JN | 1 |
| Blegniski, FP; da Silva Zanoni, KP; de Souza, SRG; Fracaro, L; Guarnier, FA; Martins, HA; Silva, TNX; Vicentini, GE; Zanoni, JN | 1 |
| Biolo, G; Cederholm, T; Muscaritoli, M | 1 |
| Bading, JR; Buijs, N; Houdijk, AP; van Leeuwen, PA; Vermeulen, MA; Weeda, VB | 1 |
| Martindale, RG; Moore, FA; Rosenthal, MD; Vanzant, EL | 1 |
| de Souza, SR; Fracaro, L; Frez, FC; Guarnier, FA; Linden, DR; Martins, HA; Silva, BC; Vicentini, GE; Zanoni, JN | 1 |
| Amsellem, C; Assenat, E; Bachmann, P; Collin, F; Courraud, J; Cristiani, I; de Forges, H; Dechelotte, P; Janiszewski, C; Khemissa, F; Mineur, L; Ramdani, M; Senesse, P | 1 |
| Bazotte, RB; Bossolani, GD; Guarnier, FA; Hermes-Uliana, C; Jussani, LA; Lima, MM; Mariani, FA; Martins, HA; Sehaber, CC; Vicentini, GE; Zanoni, JN | 1 |
| de Souza, SR; Fracaro, L; Guarnier, FA; Martins, HA; Vicentini, GE; Zanoni, JN | 1 |
| Kuhn, KS; Muscaritoli, M; Stehle, P; Wischmeyer, P | 1 |
| Noé, JE | 1 |
| Baracos, VE; Sawyer, MB; Wischmeyer, PE; Xue, H | 1 |
| Morassutti, I; Paccagnella, A; Rosti, G | 1 |
| Abilés, J; Fernández-Ortega, JF; Planas, M | 1 |
| Blesa Malpica, AL; Cervera Montes, M; Jiménez Jiménez, FJ | 1 |
| Gomes-Marcondes, MC; Salomão, EM | 1 |
| Berretta, M; Berretta, S; Cappellani, A; Di Francia, R; Fisichella, R; Galvano, F; Michieli, M; Rupolo, M; Tirelli, U | 1 |
| Lemmey, A; Maddison, P; Marcora, S | 1 |
| Berk, L; Hug, E; James, J; Kachnic, L; Mahadevan, A; Samuels, M; Schwartz, A | 1 |
| Baracos, VE; Cynober, L; Field, CJ; Le Bricon, T | 1 |
| Newsholme, EA | 2 |
| Shabert, JK; Wilmore, DW | 1 |
| Luft, FC | 1 |
| Bärtsch, P; Dröge, W; Edler, L; Fischbach, T; Friedmann, B; Hack, V; Kinscherf, R; Weiss, C | 1 |
| Breitkreutz, R; Drings, P; Dröge, W; Hack, V; Holm, E; Kinscherf, R; Schmid, D; Stahl-Henning, C; Taut, F | 1 |
| de Blaauw, I; Deutz, NE; Hulsewé, KW; Soeters, PB; van der Hulst, RR; von Meyenfeldt, MM | 1 |
| Abcouwer, SF; Elgadi, KM; Labow, BI; Souba, WW | 1 |
| Kazantzis, M; Rosa, LF; Seelaender, MC | 1 |
| de Blaauw, I; Deutz, NE; von Meyenfeldt, MF | 1 |
| Bacurau, RF; Belmonte, MA; Costa Rosa, LF; Seelaender, MC | 1 |
| Ishibashi, N; Kaibara, A; Shirouzu, K; Yoshida, S | 1 |
| Abumrad, NN; Barber, A; D'Olimpio, JT; Hourihane, A; May, PE | 1 |
| Curi, R; de Mello, MA; Ramos Lima, MM | 1 |
| Bevan, S; Bond, J; Colquhoun, A; Curi, R; Dimitriadis, GD; Leighton, B; Newsholme, EA; Parry-Billings, M | 1 |
9 review(s) available for glutamine and Cachexia
| Article | Year |
|---|---|
Glutamine as indispensable nutrient in oncology: experimental and clinical evidence.
Topics: Administration, Oral; Antineoplastic Agents; Cachexia; Glutamine; Glutathione; Humans; Infusions, Intravenous; Neoplasms; Randomized Controlled Trials as Topic | 2010 |
L-glutamine use in the treatment and prevention of mucositis and cachexia: a naturopathic perspective.
Topics: Administration, Oral; Amino Acids; Animals; Antineoplastic Agents; Cachexia; Glutamine; Humans; Mucositis; Naturopathy; Neoplasms; Radiotherapy, Adjuvant; Stomatitis | 2009 |
Nutrition modulation of gastrointestinal toxicity related to cancer chemotherapy: from preclinical findings to clinical strategy.
Topics: Antineoplastic Agents; Cachexia; Fatty Acids, Omega-3; Gastrointestinal Diseases; Glutamine; Humans; Neoplasms; Nutritional Physiological Phenomena; Probiotics; Randomized Controlled Trials as Topic | 2011 |
Nutritional intervention for improving treatment tolerance in cancer patients.
Topics: Amino Acids; Arginine; Cachexia; Dietary Supplements; Fatty Acids, Omega-3; Feeding Behavior; Glutamine; Humans; Malnutrition; Neoplasms; Nutritional Status; Nutritional Support; Weight Loss | 2011 |
Nutrition in oncologic patients during antiblastic treatment.
Topics: Antineoplastic Agents; Cachexia; Complementary Therapies; Dietary Fats, Unsaturated; Dietary Proteins; Dietary Supplements; Glutamine; Hematopoietic Stem Cell Transplantation; Humans; Intestinal Mucosa; Muscle, Skeletal; Neoplasms; Nutritional Status; Proteoglycans; Stomatitis; Trametes | 2013 |
The possible role of glutamine in some cells of the immune system and the possible consequence for the whole animal.
Topics: Animals; Burns; Cachexia; Glutamine; Humans; Lymphocytes; Macrophages; Models, Biological; Muscle, Skeletal; Sepsis; Wounds and Injuries | 1996 |
Liver protein and glutamine metabolism during cachexia.
Topics: Cachexia; Glutamine; Humans; Liver; Proteins | 1997 |
[Cachexia in cancer: disturbances in the protein and aminoacid metabolism].
Topics: Amino Acids; Animals; Cachexia; Glutamine; Humans; Muscle, Skeletal; Neoplasms; Proteins | 1999 |
Application of metabolic-control logic to the requirements for cell division.
Topics: Animals; Antineoplastic Agents; Cachexia; Cell Division; Glutamine; Glycolysis; Humans; Muscle Proteins; Neoplasms | 1990 |
8 trial(s) available for glutamine and Cachexia
| Article | Year |
|---|---|
Efficacy of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine for the prevention of mucositis induced by platinum-based chemoradiation in head and neck cancer: A phase II study.
Topics: Arginine; Cachexia; Chemoradiotherapy; Glutamine; Head and Neck Neoplasms; Humans; Mucositis; Squamous Cell Carcinoma of Head and Neck | 2023 |
Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH).
Topics: Arginine; Cachexia; Female; Glutamine; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2021 |
A phase III study evaluating oral glutamine and transforming growth factor-beta 2 on chemotherapy-induced toxicity in patients with digestive neoplasm.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cachexia; Dietary Supplements; Double-Blind Method; Female; Fluorouracil; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Glutamine; Humans; Male; Middle Aged; Platinum Compounds; Transforming Growth Factor beta | 2016 |
Dietary treatment of rheumatoid cachexia with beta-hydroxy-beta-methylbutyrate, glutamine and arginine: a randomised controlled trial.
Topics: Arginine; Arthritis, Rheumatoid; Body Composition; Body Mass Index; Cachexia; Dietary Supplements; Double-Blind Method; Female; Glutamine; Hand Strength; Humans; Male; Middle Aged; Surveys and Questionnaires; Valerates | 2005 |
A randomized, double-blind, placebo-controlled trial of a beta-hydroxyl beta-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122).
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Arginine; Cachexia; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Female; Glutamine; Humans; Male; Middle Aged; Neoplasms; Placebos; Plethysmography; Quality of Life; Statistics, Nonparametric; Treatment Outcome; Valerates | 2008 |
Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals: the effect of N-acetyl-cysteine.
Topics: Acetylcysteine; Adult; Aerobiosis; Anaerobiosis; Body Weight; Cachexia; Cystine; Exercise; Female; Glutamic Acid; Glutamine; Glycine; Humans; Male; Middle Aged; Tyrosine | 1996 |
Glutamine supplementation in cancer patients.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cachexia; Carbon Isotopes; Case-Control Studies; Combined Modality Therapy; Dietary Supplements; Disease Models, Animal; Esophageal Neoplasms; Glutamine; Humans; Male; Parenteral Nutrition, Total; Proteins; Rats | 2001 |
Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine.
Topics: Aged; Arginine; Body Composition; Cachexia; Dietary Supplements; Double-Blind Method; Drug Combinations; Female; Glutamine; Humans; Male; Middle Aged; Muscle, Skeletal; Neoplasms; Treatment Outcome; Valerates | 2002 |
24 other study(ies) available for glutamine and Cachexia
| Article | Year |
|---|---|
Alpha-Ketoglutarate Regulates Tnfrsf12a/Fn14 Expression via Histone Modification and Prevents Cancer-Induced Cachexia.
Topics: Animals; Cachexia; Cell Line, Tumor; Colonic Neoplasms; Disease Models, Animal; Glutamine; Histone Code; Histone Methyltransferases; Histones; Humans; Ketoglutaric Acids; Mice; Tumor Microenvironment; TWEAK Receptor | 2023 |
L-glutamine supplementation reduced morphological damage in the renal glomerulus of rats with Walker-256 tumor.
Topics: Animals; Cachexia; Collagen; Dietary Supplements; Fibroblast Growth Factor 2; Glutamine; Neoplasms; Rats; Rats, Wistar | 2023 |
Akt activation by insulin treatment attenuates cachexia in Walker-256 tumor-bearing rats.
Topics: Animals; Blood Glucose; Cachexia; Carcinoma 256, Walker; Drug Therapy, Combination; Glutamine; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar | 2020 |
The clinical impacts of early using glutamine/arginine enriched high protein density formula at trophic dose in intolerant enteral nutrition cachectic hypoalbuminemic hospitalized patients.
Topics: Aged; Arginine; Blood Glucose; C-Reactive Protein; Cachexia; Dietary Proteins; Enteral Nutrition; Female; Food, Formulated; Glutamine; Humans; Hypoalbuminemia; Length of Stay; Male; Malnutrition; Middle Aged; Retrospective Studies; Serum Albumin; Time Factors | 2020 |
l-Glutamine supplementation promotes an improved energetic balance in Walker-256 tumor-bearing rats.
Topics: Animals; Blood Glucose; Cachexia; Carcinoma 256, Walker; Corticosterone; Dietary Supplements; Duodenum; Gluconeogenesis; Glucose-6-Phosphatase; Glutamine; Insulin; Jejunum; Male; Models, Animal; Phosphoenolpyruvate Carboxykinase (ATP); Rats; Rats, Wistar; Urea | 2017 |
Does l-glutamine-supplemented diet extenuate NO-mediated damage on myenteric plexus of Walker 256 tumor-bearing rats?
Topics: Animals; Antioxidants; Cachexia; Carcinoma 256, Walker; Dietary Supplements; Disease Models, Animal; Glutamine; Ileum; Jejunum; Male; Myenteric Plexus; Neurons; Nitric Oxide; Nitric Oxide Synthase Type I; Oxidative Stress; Rats; Rats, Wistar; tert-Butylhydroperoxide; Tumor Burden | 2017 |
Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia.
Topics: Adipose Tissue; Aged; Aging; Body Composition; Body Mass Index; Cachexia; Chronic Disease; Energy Metabolism; Female; Glutamine; Humans; Male; Malnutrition; Muscle Contraction; Muscle, Skeletal; Nutritional Status; Obesity; Prevalence; Sarcopenia | 2014 |
Adaptations of Arginine's Intestinal-Renal Axis in Cachectic Tumor-Bearing Rats.
Topics: Animals; Arginine; Cachexia; Diet; Glutamine; Immune System; Intestinal Mucosa; Kidney; Male; Methylcholanthrene; Parenteral Nutrition; Rats; Rats, Inbred F344; Renal Circulation; Sarcoma, Experimental | 2015 |
Evolving paradigms in the nutritional support of critically ill surgical patients.
Topics: Arginine; Burns; Cachexia; Critical Illness; Enteral Nutrition; Fish Oils; Gastrointestinal Tract; Glutamine; Humans; Infusions, Intravenous; Lipids; Microbiota; Multiple Organ Failure; Muscle, Skeletal; Neoplasms; Parenteral Nutrition; Perioperative Care; Protein-Energy Malnutrition; Stress, Physiological | 2015 |
Walker 256 tumor-bearing rats demonstrate altered interstitial cells of Cajal. Effects on ICC in the Walker 256 tumor model.
Topics: Animals; Anoctamin-1; Blotting, Western; Cachexia; Carcinoma 256, Walker; Chloride Channels; Glutamine; Immunohistochemistry; Interstitial Cells of Cajal; Jejunum; Male; Myenteric Plexus; Nitric Oxide Synthase Type I; Oxidative Stress; Rats; Rats, Wistar; Tumor Burden | 2016 |
Supplementation with L-glutamine prevents tumor growth and cancer-induced cachexia as well as restores cell proliferation of intestinal mucosa of Walker-256 tumor-bearing rats.
Topics: Animals; Cachexia; Carcinogenesis; Cell Proliferation; Dietary Supplements; Glutamine; Humans; Intestinal Mucosa; Neoplasms; Rats | 2016 |
Experimental Cancer Cachexia Changes Neuron Numbers and Peptide Levels in the Intestine: Partial Protective Effects after Dietary Supplementation with L-Glutamine.
Topics: Cachexia; Cell Line, Tumor; Dietary Supplements; Glutamine; Humans; Intestinal Mucosa; Neoplasms; Neurons | 2016 |
[Guidelines for specialized nutritional and metabolic support in the critically-ill patient. Update. Consensus of the Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE): oncoh
Topics: Cachexia; Critical Care; Critical Illness; Dietary Fats; Eicosapentaenoic Acid; Energy Intake; Energy Metabolism; Enteral Nutrition; Glutamine; Humans; Inflammation; Neoplasms; Nutritional Requirements; Parenteral Nutrition; Postoperative Care; Societies, Medical; Societies, Scientific; Spain | 2011 |
[Guidelines for specialized nutritional and metabolic support in the critically-ill patient. Update. Consensus of the Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE): cardi
Topics: Acute Coronary Syndrome; Cachexia; Cardiac Surgical Procedures; Critical Care; Critical Illness; Death, Sudden, Cardiac; Diet, Sodium-Restricted; Dietary Proteins; Energy Metabolism; Enteral Nutrition; Fatty Acids, Omega-3; Food, Formulated; Glutamine; Heart Diseases; Humans; Malnutrition; Myocytes, Cardiac; Parenteral Nutrition; Postoperative Complications; Societies, Medical; Societies, Scientific; Spain | 2011 |
Light aerobic physical exercise in combination with leucine and/or glutamine-rich diet can improve the body composition and muscle protein metabolism in young tumor-bearing rats.
Topics: Animals; Cachexia; Carcinoma 256, Walker; Dietary Supplements; Exercise Therapy; Glutamine; Leucine; Male; Neoplasm Transplantation; Physical Conditioning, Animal; Rats; Rats, Wistar; Tumor Burden; Weight Gain | 2012 |
Supplemental nutrition with ornithine alpha-ketoglutarate in rats with cancer-associated cachexia: surgical treatment of the tumor improves efficacy of nutritional support.
Topics: Amino Acids; Animals; Body Weight; Cachexia; Combined Modality Therapy; Eating; Food, Fortified; Glutamine; Glycine; Intestine, Small; Liver Neoplasms, Experimental; Male; Muscle, Skeletal; Neoplasm Proteins; Nitrogen; Ornithine; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured | 1995 |
Glutamine deficiency as a cause of human immunodeficiency virus wasting.
Topics: Animals; Cachexia; Energy Metabolism; Glutamine; Glutathione; HIV Infections; Homeostasis; Humans; Intestinal Absorption; Intestinal Mucosa; Weight Loss | 1996 |
Starvation in a sea of plenty: can a "slime loosener" help the critically ill?
Topics: Acetylcysteine; Cachexia; Glutamine; Humans; Intracellular Fluid; Weight Loss | 1996 |
Cystine levels, cystine flux, and protein catabolism in cancer cachexia, HIV/SIV infection, and senescence.
Topics: Adipose Tissue; Adolescent; Adult; Aging; Animals; Cachexia; CD4 Lymphocyte Count; Citrulline; Cystine; Female; Glutamine; HIV Infections; Humans; Macaca; Male; Middle Aged; Muscle Proteins; Muscle, Skeletal; Neoplasms; Simian Acquired Immunodeficiency Syndrome; Taurine | 1997 |
Sepsis increases lung glutamine synthetase expression in the tumor-bearing host.
Topics: Animals; Blotting, Western; Cachexia; Fibrosarcoma; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glutamate-Ammonia Ligase; Glutamine; Lipopolysaccharides; Lung; Male; Muscle Neoplasms; Muscle, Skeletal; Rats; Rats, Inbred F344; RNA, Messenger; Sepsis | 1998 |
The effect of Walker-256 tumour development upon Kupffer cell metabolism.
Topics: Amino Acids, Dicarboxylic; Animals; Cachexia; Carcinoma 256, Walker; Glucose; Glutamine; Hexokinase; Kupffer Cells; Lactates; Macrophages, Peritoneal; Male; Palmitates; Rats; Rats, Wistar | 1998 |
Effect of a moderate intensity exercise training protocol on the metabolism of macrophages and lymphocytes of tumour-bearing rats.
Topics: Animals; Cachexia; Carcinoma 256, Walker; Glucose; Glutamine; Hydrogen Peroxide; Lactates; Lymphocyte Activation; Lymphocytes; Macrophages; Male; Phagocytosis; Physical Conditioning, Animal; Rats; Rats, Wistar | 2000 |
Walker 256 tumour growth causes marked changes of glutamine metabolism in rat small intestine.
Topics: Animals; Cachexia; Carcinoma 256, Walker; Glutamine; Intestine, Small; Male; Neoplasm Transplantation; Rats; Rats, Wistar | 2002 |
The effect of tumour bearing on skeletal muscle glutamine metabolism.
Topics: Animals; Cachexia; Glutamine; Kinetics; Male; Muscles; Neoplasms, Experimental; Rats; Rats, Inbred Strains | 1991 |